AKT1 and Hyperglycemia: A recent single-center retrospective cohort study of 491 patients treated with PI3K and/or AKT inhibitors identified BMI >25 kg/m2 and HbA1C > 5.7% as independent predictors of hyperglycemia in a multivariate regression model (6).